Linking Financial Market Institutions, Corporate Finance, and Competitive Strategies
Linking Financial Market Institutions, Corporate Finance, and Competitive Strategies
This chapter analyses how firms can compete despite comparative disadvantages of national financial-market institutions. It first studies whether pharmaceutical firms in Germany, Italy, and the UK require different types of financing to pursue strategies of radical product innovation, incremental product innovation, and product imitation, respectively. Since quantitative analyses of corporate balance sheets show this to be the case, the chapter goes on to ask how firms can acquire the necessary financial means if their provision is limited by unfavourable national institutions. Illustrating how firms collaborate with foreign investors, it identifies international financial markets as a functional equivalent to national institutions promoting the availability of institutional (venture) capital. It concludes with reflections on how these findings contribute to the resource-based view and the competitiveness literature, and illustrates how a Schumpeterian perception of firms as creative entrepreneurs helps to explain how they compete despite comparative institutional disadvantages.
Keywords: financing, innovation strategies, comparative disadvantages, functional equivalents, resource-based view, competitiveness theories, Schumpeter
Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
Please, subscribe or login to access full text content.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .
